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Abstract.  A  monoclonal antibody that reacts with 
proteins in the nuclear pore complex of rat liver 
(Snow, C. M., A.  Senior, and L. Gerace.  1987.  J. 
Cell Biol.  104:1143-1156)  has been shown to cross 
react with similar components in Xenopus oocytes, as 
determined by immunofluorescence microscopy and 
immunoblotting. We have microinjected the antibody 
into oocytes to study the possible role of these poly- 
peptides in nucleocytoplasmic transport.  The antibody 
inhibits import of a  large nuclear protein, nucleoplas- 
min, in a  time- and concentration-dependent manner. 
It also inhibits export of 5S ribosomal RNA and ma- 
ture tRNA, but has no effect on transcription or in- 
tranuclear tRNA processing. The antibody does not 
affect the rate of diffusion into the nucleus of two 
small proteins, myoglobin and ovalbumin, indicating 
that antibody binding does not result in occlusion of 
the channel for diffusion. This suggests that inhibition 
of protein and RNA transport occurs by binding of the 
antibody at or near components of the pore that par- 
ticipate in mediated transport. 
M 
OLECULAR traffic between the nuclear and cyto- 
plasmic compartments of the eukaryotic cell takes 
place through pore complexes that perforate the 
nuclear envelope (for reviews see references 11, 14, and 23). 
The pore complex is a supramolecular protein assembly that 
forms an aqueous channel through the double-nuclear mem- 
brane at points where the inner and outer membranes are 
fused (23,  51). As  seen by electron microscopy, the pore 
complex contains two eightfold symmetrical rings with outer 
diameters of 120  nm,  one on each  face of the envelope, 
which surround a central channel (24, 51). Radial spokes ap- 
pear to project inward from the walls of the channel, where 
a central particle can often be found (51). Since transport ap- 
pears to take place through the center of this channel (21), 
the central particle may contain material in the process of be- 
ing transported. 
The nuclear pore complex behaves as a molecular sieve 
that allows the passive diffusion of solutes at a rate inversely 
proportional to molecular size, up to a limit of 9-11 nm diam 
(2, 41-44). Thus, globular proteins of less than "020 kD will 
readily diffuse across the envelope, while proteins of more 
than ,065 kD are effectively excluded (2). Because many nu- 
clear proteins are larger than the limit for diffusion, or would 
diffuse too slowly across the envelope to account for their 
physiological rates of appearance  in  the nucleus  (3,  20), 
transport of most nuclear proteins is thought to be achieved 
by a mediated mechanism. 
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Several nuclear proteins have been shown to contain short 
stretches of amino acids that confer a nuclear location on the 
protein (for examples see references 27, 31, 32, 34, 46, 53). 
This suggests that nuclear proteins might interact with one 
or several  receptors for these sequences, most probably lo- 
cated in the pore complex. Export of RNA also appears to 
take place by a mediated mechanism that can be saturated, 
as suggested by work with transfer RNA (55).  Therefore, 
receptors  are  also  likely to exist for RNA and/or RNPs. 
Receptors appear to act in a vectorial fashion because pro- 
teins that are freely diffusible inside the nucleus (44) do not 
appear to be transported back to the cytoplasm. 
The pore complex can transport very large particles, as 
demonstrated by injection of colloidal gold particles con- 
jugated to a nuclear protein into the cytoplasm of Xenopus 
oocytes. Particles of more than 20 nm diam were found to 
pass through the central channel as readily as smaller parti- 
cles (21). Transport of these gold particles was dependent 
upon their conjugation with a protein that contains a signal 
for nuclear location. The ability of  the pore complex to trans- 
port such large particles suggests that the channel may be 
gated to open from 10 nm to >20 nm upon interaction with 
a protein containing a nuclear location signal. Evidence from 
in vivo and cell-free systems to study nuclear protein import 
indicate that transport is likely to be ATP dependent (38, 40, 
45) and, in the absence of ATP, nuclear proteins will bind 
to the pore complex but will not be transported (39, 45). 
Despite  considerable  interest  in  the  ultrastructure  and 
functions of the  pore  complex,  relatively little is  known 
about its molecular composition. An integral membrane gly- 
coprotein of 190,000 Mr (25)  was identified biochemically 
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to the pore complex by immunocytochemistry. On the basis 
of its biochemical characteristics, this protein could plausi- 
bly serve to anchor the complex to the lipid bilayer (25). 
More recently, several groups have used monoclonal anti- 
bodies to identify less abundant protein components of the 
pore complex (9,  10, 28, 49). All of these antibodies recog- 
nize proteins that are O-glycosylated with N-acetyl glucos- 
amine. The antibodies raised by Snow et al. identify several 
distinct epitopes on a group of eight pore complex polypep- 
tides, in which the sugar residues contribute to the antibody 
binding site (30). These eight polypeptides may be important 
in nuclear transport for several reasons: there are estimated 
to be between two and eight copies of each polypeptide per 
pore complex, which probably contribute <15 % of the pore 
complex mass  (49),  a  figure more consistent with a func- 
tional role in transport than a purely structural role; they are 
located in the rings,  the parts of the pore presented to the 
nucleoplasm and cytoplasm that might be expected to contain 
receptors and other parts of the translocation apparatus, and 
at least one of the polypeptides is asymmetrically disposed 
on only the nucleoplasmic face of the envelope, as one would 
expect for components involved in vectorial transport. 
As a first step to study the possible functional roles of  these 
pore complex proteins, we have examined the effects of the 
antibodies on nucleocytoplasmic transport in vivo in Xeno- 
pus oocytes. Here we present evidence that one antibody in- 
hibits  nucleocytoplasmic  transport  of protein  and  RNA, 
while having no discernable effect on diffusion through the 
pore. We conclude that transport may be inhibited by anti- 
body binding at or near pore complex components that are 
involved in mediated nuclear transport. 
Materials and Methods 
Frogs and Oocytes 
Mature Xenopus laevis were obtained from Xenopus I, (Ann Arbor, MI). 
They were kept at 20°C with a cycle of 15 h light, 9 h dark, and fed frog 
brittle (Nasco, Fort Atkinson, WI). Pieces of  ovary were surgically removed 
after anaesthetizing the animal with 0.2%  (wt/vol) 3-aminobenzoic acid 
ethyl ester in 50 mM Tris-HCl, pH 7.5. Ovary was washed briefly in OR-2 
(82.5  mM  NaCI,  2.5  mM  KCI,  1  mM  CaCI2,  1  mM  MgCIz,  1  mM 
Na2HPO4,  5 mM Hepes-KOH, pH 7.8; Wallace et al.  [52])  and oocytes 
were released from the ovary by digestion with 2 mg/ml coUagenase (Type 
II; Sigma Chemical Co., St. Louis, MO) in calcium-free OR-2 for 2-3 h 
at room temperature. Mature stage 6 oocytes (17) were selected under the 
microscope and incubated overnight at 20°C in OR-2 before injection to se- 
lect against those oocytes that die soon after isolation. 
Antibodies 
RLI (IgM) and RL7 (IgG1) are mouse monoclonal anti-pore complex anti- 
bodies described by Snow et al. (49).  MS1 (IgM) is a mouse monoclonal 
anti-ferritin, a generous gift of Dr.  Metre Strand (Department of Pharma- 
cology, Johns Hopkins University School of Medicine, Baltimore, MD). 
The IgMs were purified from mouse ascites fluid by chromatography on 
Sephacryl $400 in 50 mM Tris-HCl, pH 8.8, 500 mM KCI, 0.02%  (wt/vol) 
NAN3. The IgG was purified by protein A-Sepharose affinity chromatogra- 
phy as described by Ey et al. (19). All antibodies were concentrated on Ami- 
con PMI0 membranes (Amicon, Danvers, MA) and dialyzed against 50% 
(vol/vol) glycerol in PBS for storage at -20°C. Antibodies were conjugated 
to cyanogen bromide-activated Sepharose 4B (Pharmacia Fine Chemicals, 
Piscataway,  N  J) according to the manufacturer's directions, to give a final 
antibody concentration of  4-5 mg/ml beads. For injection into oocytes, anti- 
bodies stored in glycerol were dialysed extensively against D-PBS (Gibco 
1.  Abbreviations  used  in  this  paper:  D-PBS,  Dulbecco's  formulation 
phosphate-buffered saline; WGA, wheat germ agglutinin. 
Laboratories, Grand Island, NY) and concentrated to 15 mg/ml on Centri- 
con 30 (Amicon). Protein concentrations were determined by the method 
of Bradford (4) using mouse IgG as standard. 
lodinated Proteins 
Chicken egg white ovalbumin, sperm whale myoglobin, and Staphylococcus 
aureus protein A were obtained from Sigma Chemical Co. Nucleoplasmin 
was prepared from X.  laevis eggs essentially as described by Dingwall et 
al. (16) except that the clarified extract was treated at 80°C for 10 min (35) 
before chromatography on DEAE cellulose and  phenyl Sepharose.  Nu- 
cleoplasmin, ovalbumin,  and m3~globin were radioiodinated  with p25I]Bol- 
ton-Hunter reagent (1) and dialyzed against 0.1 mM EDTA, 50 mM NaC1, 
25  mM Hepes-NaOH, pH 7.5 to remove unreacted label. In the case of 
nucleoplasmin, unlabeled ovalbumin was added as a carrier before the dial- 
ysis step to give a final concentration of 2 mg/ml. The final concentration 
of ~25I was  1.5  x  105 cpm/I.tl,  "°2  ×  106 cpm/~g nucleoplasmin. More 
than 99% of the total  ~25I was TCA insoluble. Protein A was iodinated by 
the chloramine-T procedure (26)  to a final concentration of 2  ×  105 cpm/ 
gl,  108 cpm/Ixg. 
Protein Import Experiments 
Oocytes, antibodies, and ~251-1abeled proteins were prepared for injection 
as  described above.  Oocytes  were  transferred to  OR-2  containing  1% 
(wt/vol) Ficol1400 (Sigma Chemical Co.) and injected in the vegetal hemi- 
sphere with 100 nl antibody or D-PBS using needles drawn from 0.008  in 
internal  diameter  precision  bore  glass  tubing  (Drummond  Scientific, 
Broomall PA). After injection they were returned to OR-2 and incubated at 
20°C for 2 h. They were then injected in the vegetal hemisphere with 25-50 
nl ~25I-protein  and incubated further at 20°C. At the appropriate times, oo- 
cytes were fixed with 20% (wt/vol) ice-cold TCA for 60 min (2), the nuclei 
were  manually  dissected  from  the  oocytes  and  individual  nuclei  and 
cytoplasms were counted in a gamma counter. Transport into the nucleus 
was calculated as the percentage of the total cellular radioactivity in the nu- 
cleus for individual oocytes. 
RNA Export Experiments 
Plasmid constructions were as previously described: pXbsl contains a sin- 
gle copy of a somatic-type Xenopus laevis 5S ribosomal RNA gene (47), 
and pXIt  m~t encodes a  Xenopus laevis methionyl transfer RNA gene (6). 
DNAs were precipitated with ethanol, dissolved in D-PBS, and mixed with 
the appropriate antibody solution to give a final concentration of 0.2 mg/ml 
for each plasmid and 10 mg/ml antibody. Oocytes were incubated at 19°C 
throughout the experiments. For nuclear injections of antibody 25  nl of 
DNA-antibody solution was injected. The oocytes were incubated for 3 h, 
then newly synthesized RNA transcripts were labeled by injection of 25 nl 
a32p-GTP  (20  mCi/ml,  600 Ci/mMol) (New England Nuclear,  Boston, 
MA) followed by incubation for 2.5 h. For cytoplasmic injections, 50 nl of 
15 mg/ml antibody solution was first injected into the vegetal hemisphere 
of the oocyte, followed 2 h later by injection of 25 nl of D-PBS containing 
0.2 mg/ml pXbs and 0.2 mg/ml pXlt  "~ into the nucleus. The oocytes were 
incubated for 2  h after injection of DNA, then RNA was labeled as de- 
scribed above. Nuclei and cytoplasms were manually dissected in I00 mM 
KCI, 20 mM NaCl, 3 mM MgCI2,  1 mM DTT,  l0 mM Tris-HCl, pH 7.5, 
containing 2% (wt/vol) polyvinylpyrrolidone (37).  For each condition nu- 
clear and cytoplasmic fractions from l0 oocytes were pooled and homog- 
enized in 0.5 ml 150 mM NaCI, 5 mM EDTA, 50 mM Tris-HCl, pH 7.4, 
containing  1%  (wt/vol)  SDS  and  100  gg/ml  proteinase K  (Boehringer 
Mannheim, Indianapolis, IN). RNA was purified by two phenol extractions 
followed by one chloroform extraction, and precipitated with ethanol. RNA 
was dissolved in a 95 % (vol/vol) formamide-containing buffer and separated 
by denaturing electrophoresis on an 8% (wt/vol) polyacrylamide gel as de- 
scribed by Sakonju et al. (47). 
Immunofluorescence Microscopy 
Small pieces of unfixed ovary were rapidly frozen in liquid nitrogen-cooled 
isopentane and embedded in O.C.T. compound (Miles Scientific, Naper- 
ville, IL). Sections of 5 gm were cut with a cryostat, the sections were fixed 
on microscope slides by immersion in ice-cold absolute methanol for 10 
rain, and returned to PBS without drying. Fixation of  the ovary before freez- 
ing, or drying of sections resulted in loss of immunoreactivity. Sections 
were processed for indirect immunofluorescence  microscopy using 17 gg/ml 
monoclonal antibody followed by rhodamine-conjugated goat anti-mouse 
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was performed using a Zeiss Photomicroscope III with a 25× objective and 
Tri-X pan film. 
SDS Gel Electrophoresis and Immunoblotting 
Nuclei were isolated from oocytes that were fixed in ice-cold 20% (wt/vol) 
TCA for 15 min and solubilized in SDS gel sample buffer by sonication and 
boiling. The proteins were separated by SDS-PAGE as described by Maizel 
(36) and electroblotted onto nitrocellulose as described by Burnette (5) with 
the modifications of Gerace et al. (25). Blots were probed with monoctonal 
antibodies  followed by  rabbit anti-mouse IgG  and  ~2SI-protein A,  and 
processed for autoradiography as described by Snow et al. (49). 
Results 
Immunoreactivity of  RLI with the Nuclear Envelope  of 
Xenopus Oocytes 
A number of monoclonal antibodies that recognize the nu- 
clear pore complex have been characterized in rat liver nu- 
clear envelopes and cultured normal rat kidney cells (49). To 
use these antibodies to study nuclear transport by microin- 
jection into Xenopus oocytes, we first established their cross- 
reactivity with Xenopus. 
By indirect immunofluorescence microscopy all of these 
antibodies labeled the nuclear surface of  the Xenopus A6 kid- 
ney cell line in a finely punctate pattern, like that seen with 
mammalian cells (data not shown).  This indicates that the 
epitopes are all present in some Xenopus somatic cells, how- 
ever, only RL1 was found to react strongly with Xenopus oo- 
cytes. On cryostat sections of ovary tissue RL1 stains the nu- 
clear envelope exclusively (Fig.  1). It reacts with all stages 
of oocyte development. The complete nuclear envelope is 
most easily seen in early, pre-vitellogenic stages (Fig.  1, C 
and D). The appearance in mature oocytes (Fig. 1, A and B) 
is somewhat fragmented as a result of difficulty sectioning 
these large,  unfixed cells.  Interestingly, the nuclear enve- 
lopes of the  follicle cells  surrounding  the oocyte are  not 
stained by RL1. Antibody RL7, which reacts with a different 
epitope on a subset of the rat liver RL1 antigens (Snow,  C., 
A. Senior, and L. Gerace, unpublished results; see Fig. 2 e) 
does not react with sections of any stage of oocyte (Fig.  1, 
E-H). 
To identify the polypeptides recognized by RL1 in oocytes, 
nuclei were manually isolated and analyzed directly on im- 
munoblots with RL1. The two major polypeptides that are la- 
beled with RL1 have apparent molecular weights of 180,000 
and 60,000 (Fig. 2, b and c). They are specifically labeled 
by RLI but not by RL7 (Fig. 2f) or MS1, a control antibody 
of the same class as RL1 (Fig. 2 h). These polypeptides are 
very similar in molecular weight to two major immunoreac- 
tive  polypeptides  found  in  rat  liver, nuclear  envelopes 
(180,000  and 63,000 Mr) (Fig. 2 a). When more nuclei are 
loaded onto the blot several more minor immunoreactive 
polypeptides can be identified (Fig.  2 d).  No other major 
polypeptides are identified when whole oocytes are immuno- 
adsorbed with RL1  and the adsorbed material is immuno- 
blotted with the same antibody (data not shown). When con- 
sidered together with the immunofluorescence data presented 
in Fig. 1, this provides good evidence that the antigens recog- 
nized by RL1 in oocytes are located in the nuclear envelope, 
and  most probably  are  pore complex components  of the 
Xenopus oocyte. This conclusion is supported by immuno- 
gold labeling of the nuclear pore complexes with RL1  on 
whole-mount Xenopus oocyte nuclear envelopes (McDowell, 
A., and G. Griffiths, unpublished results). 
Inhibition of  Nuclear Protein Import 
To test the effect of RL1 on nuclear protein import into the 
nucleus we chose to use nucleoplasmin as a model protein. 
Nucleoplasmin is a large protein of Xenopus oocyte nuclei 
that contains nuclear location signals that allow its accumu- 
lation in the nucleus,  apparently by a  mediated transport 
mechanism (14-16). When t25I-labeled nucleoplasmin is in- 
jected into the cytoplasm of oocytes it rapidly accumulates 
in the nucleus (16). 
Oocytes were first injected with antibody to give a final cy- 
toplasmic concentration of 1.0-1.5  mg/ml. They were then 
incubated at room temperature for 2 h to allow binding of the 
antibody before being injected with ~z~I-nucleoplasmin.  By 
SDS-PAGE and  immunoblotting both  nucleoplasmin  and 
antibodies are stable in the oocyte for at least 24 h (data not 
shown).  Oocytes injected with RL1  survive incubation at 
room temperature for more than 20 h. Over the course of 3 h 
oocytes were analyzed for the distribution of radiolabeled 
nucleoplasmin between nucleus and cytoplasm (Fig. 3). RL1 
dramatically inhibits the accumulation of nucleoplasmin in 
the nucleus when compared to accumulation in control oo- 
cytes injected with buffer (Fig. 3 A). Neither RL7 (Fig. 3 B) 
nor MS1 (Fig. 3 C) significantly inhibits nucleoplasmin im- 
port in similar experiments. (The absolute amount of trans- 
port varies with the batch of oocytes used and the preparation 
of radiolabeled  nucleoplasmin,  therefore, all  experiments 
are compared with transport in oocytes that were injected 
with buffer alone.) After a 2-h incubation, the mean inhibi- 
tion by RL1 with respect to the D-PBS control was 55 % for 
three separate experiments (Table I). This is probably a con- 
servative estimate because the percentage of t~I in the nu- 
cleus at time zero was always greater than zero. This may be 
due in part to rapid transport of nucleoplasmin into the nu- 
cleus (the approximate time between injection and fixation 
was ,-02 min), to some freely diffusible ~zsI in the nucleo- 
plasmin preparation, or contamination of the nuclei with a 
small amount of adherent cytoplasm. In these experiments 
the mean value at time zero was 6.4 % (30 measurements), 
thus the extent of inhibition is ~70%. 
The extent of inhibition of transport at 2 h  is dependent 
upon the concentration of injected antibody, with 50% inhi- 
bition at ,,ol0 mg/ml in the needle (Fig. 4), which results in 
a final concentration of ,,ol mg/ml in the oocyte cytoplasm, 
assuming that the volume of an oocyte is  1 ltl. 
Inhibition of  RNA Export 
We extended these studies to consider export of RNA from 
the nucleus. To achieve a strong and specific signal we have 
used 5S RNA and tRNA  met expressed from cloned genes in- 
jected into the nucleus. In these experiments a mixture of the 
two genes was injected into the nucleus along with RL1. The 
oocytes were incubated for 3 h, then newly synthesized RNA 
was labeled with ¢t32P-GTP by injection of the label into the 
cytoplasm.  After 2.5  h,  the  nuclei  and  cytoplasms  were 
manually dissected,  RNA  was  extracted and  analyzed by 
acrylamide gel electrophoresis. 
RL1 injected into the nucleus results in inhibition of export 
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Inhibition 
RLI  D-PBS  by RLI 
% 
% '2sI in nucleus 
after 2 h  11.9  -1- 0.4 (3)  26.2  +  3.4 (3)  55.6 
Assays were performed as described in the legend to Fig. 3. The numbers 
shown are means +  SEM for three experiments. 
Figure 2.  Immunoblotting of Xenopus oocyte nuclei  with  RL1. 
Xenopus oocyte nuclei were manually dissected, subjected to SDS- 
PAGE, immunoblotted, and probed with RLI, RL7, or MS1. (Lanes 
a, e, and g) Salt-washed rat liver nuclear envelopes probed with 
RL1,  RL7, and MSI, respectively. (Lanes b, c, and d) 5,  10, and 
50 ooeyte nuclei, respectively, probed with RLI. (Lanes f  and h) 
50  oocyte nuclei probed with  RL7  and  MS1,  respectively. The 
markers to the left indicate the positions and  relative molecular 
masses (kD) of three rat liver pore complex antigens. The white 
spots on lane b indicate the two major immunoreactive species in 
the oocyte. 
of 5S RNA and mature tRNA  met when compared to control 
oocytes that were injected with D-PBS (Fig. 5). The control 
antibody RL7 has no effect on export of either RNA.  RL1 
does not inhibit transcription of either RNA species or the 
processing of tRNA to the mature form (tRNA precursors 
can be seen upon longer exposure). This indicates that injec- 
tion of the antibody does not result in gross functional abnor- 
malities in the nucleus. RL1 also inhibits RNA export when 
injected into the cytoplasm (Fig. 5  g-l). This  inhibition is 
generally less marked than when the antibody is injected into 
the  nucleus.  Quantitation  of inhibition of 5S  and tRNA  met 
export by RLI is summarized in Table II. 5S RNA export was 
inhibited by 70%  and tRNA  m~t export was inhibited by 46% 
when  RL1  was  injected  into  the  nucleus.  RL7,  and  other 
anti-pore complex antibodies, had no  significant effect on 
export. When injected into the cytoplasm, RL1 inhibited ex- 
Figure 3.  Inhibition of nucleoplasmin import by 
RLI. Stage 6 oocytes were injected in the vegetal 
hemisphere of the cytoplasm with antibodies (A-C, 
solid symbols) or with buffer alone (A-C, open 
symbols), incubated  for 2  h  then  injected with 
'2~I-labeled nucleoplasmin. At the indicated times 
oocytes were fixed with TCA and dissected into 
nuclei  and  cytoplasms.  125I in the two  fractions 
was determined by counting in a gamma counter. 
RL1 (A), RL7 (B), MSI (C). The points are means 
of five oocytes, error bars indicate the SEMs. An 
autoradiogram  of  the  iodinated  nucleoplasmin 
preparation after SDS-gel electrophoresis is shown 
in D. 
Figure 1. Immunofluorescence staining ofXenopus oocytes with RLI. 5-1am cryostat sections of Xenopus ovary were fixed in ice-cold 100% 
methanol and labeled with RL1 (A-D)  or RL7 (E-H) followed by rhodamine-conjugated rabbit anti-mouse. RLI stains the nuclear envelope 
of all stages of oocyte, RL7 is negative for all stages. (A, B, E and F) Previtellogenic oocytes; (C, D, G, and H) mature oocytes. (A, C, 
E, and G) immunofluorescence. (B, D, F, and H) phase contrast. Bar, 50 I.tm. 
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Figure 4.  Titration of RL1  in 
the  inhibition assay.  Oocytes 
were  injected  with  RL1  in 
D-PBS  at  concentrations  in 
the needle as indicated. They 
were  then  incubated for 2  h 
before injection of ~25I-nucleo- 
plasmin.  Transport  into  the 
nucleus was assayed after 2 h 
as described in the legend to 
Fig. 3.  The points are means 
of ten oocytes, error bars indi- 
cate the SEMs. 
Table II. Inhibition of  RNA Export by RL1 
Injected into nucleus  Injected into cytoplasm 
RL1  RL7  RL1  RL7 
5S RNA  30  +  6 (3)  113  29  99 
tRNA  m~  54  +  11  (3)  101  91  98 
Assays were performed  as described  in the legend  to Fig. 5. The radioactive 
gel bands  were  excised  and counted  in a scintillation  counter  and the percentage 
of each RNA exported  was calculated  with respect  to the export seen with oo- 
cytes injected  with D-PBS only. The numbers in the first column are means + 
SEM for three experiments. 
port of5S RNA by 71%, but had only a slight inhibitory effect 
on  tRNA  m~t  export.  Inhibition  of RNA  export  was  more 
pronounced  when  export  was  saturated  (55)  by  injecting 
larger amounts of plasmids containing multiple copies of the 
RNA genes (data not shown). 
Effect of  RLl on Diffusion Through the Pore 
One obvious mechanism that could account for the inhibition 
of nuclear transport described above is wholesale occlusion 
of  the aqueous channel of  the pore complex as a result of anti- 
body binding. To test the possibility that RL1 binding blocks 
the  lO-nm  channel  for  diffusion  we  analyzed  the  rate  of 
diffusion of small proteins from cytoplasm to nucleus. 
These  experiments  were  performed exactly as  with  nu- 
cleoplasmin, using  125I-labeled myoglobin (18,000  Mr)  and 
ovalbumin  (43,000  Mr).  Myoglobin is  much  smaller than 
the limit for diffusion and equilibrates rapidly between the 
nucleus and cytoplasm (41).  Previous injection of RL1  into 
the cytoplasm has no effect on the rate or extent of diffusion 
of this molecule (Fig. 6 A). Ovalbumin is closer to the size 
limit for exclusion from  the nucleus,  and  so diffuses very 
slowly  from  cytoplasm  to  nucleus.  Again,  no  significant 
difference in the  rate of diffusion was  observed over  15  h 
(Fig. 6  B). This data shows that antibody binding does not 
occlude the channel  for passive diffusion,  and  the lack of 
effect on  the  rate of diffusion suggests that the overall di- 
ameter of the diffusion channel is not significantly altered by 
antibody binding. 
Discussion 
Cross-Reaction of  RL Antibodies 14qth Xenopus Oocytes 
We have shown that RL1, a monoclonal antibody specific for 
the pore complex of rat liver nuclear envelopes, also labels 
Figure 5.  Inhibition of RNA ex- 
port  by  RL1.  Oocytes were  in- 
jected either in the nucleus with a 
mixture of antibody and plasmids 
encoding 5S ribosomal RNA and 
tRNA  ~t (nuclear injection), or in 
the vegetal hemisphere of the cy- 
toplasm with antibody then in the 
nucleus with the plasmid DNAs 
(cytoplasmic  injection).  Newly 
transcribed RNA was labeled by 
injecting  a32p-GTP.  The  nuclei 
(N) and cytoplasms (C) were dis- 
sected,  the  RNA  was  extracted 
and  separated  on  a  denaturing 
polyacrylamide gel. The gel was 
dried and  subjected to autoradi- 
ography.  (Control) Oocytes  in- 
jected  with  D-PBS.  (R/_2) Oo- 
cytes  injected  with  RL1.  (RL7) 
Oocytes injected with RL7. Each 
lane represents two oocyte equiv- 
alents from a pool of 10 oocytes. 
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proteins into the nucleus. The experiment was car- 
ried out as described in the legend to Fig. 3, but 
the oocytes were injected with  t25I-labeled myo- 
globin (A) or  t25I-labeled ovalbumin (B)~ Open 
symbols are  oocytes injected with buffer alone, 
closed symbols are oocytes injected with RL1. The 
points are means of five oocytes. The panels show 
autoradiograms of the labeled proteins after SDS- 
gel electrophoresis. 
the nuclear envelope of Xenopus oocytes and somatic cells. 
In rat liver the antibody reacts with a group of nuclear pore 
complex  glycoproteins  that  share  an  epitope  containing 
N-acetyl glucosamine linked to serine (30, 49). At least two 
polypeptides with similar apparent molecular weights to the 
rat liver polypeptides are recognized in Xenopus oocytes, 
suggesting that these are pore complex polypeptides bearing 
the same modification. This possibility is supported by the 
observation that the antibody stains Xenopus somatic cells in 
culture in a way typical of pore complex staining in other cell 
types, and by immunoelectron microscopy on whole-mount 
oocyte nuclear envelopes (McDowell, A., and G. Griffiths, 
unpublished results). 
Among several antibodies tested, only RL1 reacted strong- 
ly with proteins in Xenopus oocytes. Since all of the antibod- 
ies label the pore complex of Xenopus A6 cells, this suggests 
that there is cell-specific expression of the epitopes within 
this species. This is supported further by the finding that the 
follicle cells surrounding the oocyte do not stain with RL1. 
This differential expression could be due to different extents 
of glycosylation of the  polypeptides,  or  to  expression of 
different protein isotypes in various cell types analogous to 
the cell-specific expression of another class of nuclear enve- 
lope proteins, the lamins (33, 50), as well as numerous other 
cellular proteins. This provides circumstantial evidence that 
the structure of the pore complex is modulated in different 
cell types,  perhaps  reflecting regulation of the  functional 
properties of the pore complex in different cells. 
Inhibition of  Nuclear Transport 
Nucleoplasmin  is  an  excellent model  to  study  mediated 
protein  import  into  the  nucleus  because  it  is  very well- 
characterized with respect to its tertiary structure, stability, 
and ability to be transported into the nucleus after radioiodi- 
nation (16).  A COOH-terminal domain of '~5 kD contains 
the information for nuclear location, since cleavage of this 
domain  with  proteases  produces  a  transport-incompetent 
fragment. The COOH terminus contains several putative nu- 
clear location signals, two similar in sequence to that of the 
SV-40 virus large T antigen (15, 31, 34). Large T antigen-like 
signal sequences have been found in several nuclear proteins 
(for examples  see  references 46,  53),  suggesting  that  the 
transport apparatus is shared. It is, therefore, likely that RL1 
will inhibit import of many nuclear proteins. 
RL1 inhibits import of nucleoplasmin in a time- and con- 
centration-dependent  manner.  Transport  is  unaffected by 
other antibodies that do not react with oocyte proteins, in- 
cluding other antibodies that recognize different epitopes on 
the rat liver glycoproteins and a control IgM antibody. This 
suggests strongly that the antibody inhibits transport by bind- 
ing  to the pore complex of the oocyte, and  confirms the 
morphological observations of Feldherr and colleagues that 
transport of nucleoplasmin (21) and RNA (18) takes place 
through the pore. Despite the likelihood that each pore com- 
plex binds several antibody molecules, RL1 does not prevent 
the passive diffusion of myoglobin or ovalbumin into the nu- 
cleus.  Since the rate of diffusion is proportional to the di- 
ameter of the pore, the lack of  effect  of RL1 suggests that anti- 
body binding does not significantly alter the  10-nm-diam 
channel for diffusion. From immunoelectron microscopy on 
rat liver nuclear envelopes,  it appears  that the antibodies 
bind to material in the rings, therefore it is quite feasible that 
this binding does not encroach upon the central channel. 
A number of mechanisms could account for the inhibition 
of nuclear protein import by RL1. Since the antibody appears 
to slow the rate of transport rather than causing a total block, 
it is plausible that it binds to receptors, decreasing the num- 
ber available for interaction with nuclear proteins, or slows 
the translocation step by preventing interaction with compo- 
nents active in subsequent steps of transport. Alternatively, 
RL1 may have a steric blocking effect on the gated channel 
or on other structural changes that may be required for medi- 
ated  transport.  The  antibody could  also  inhibit  mediated 
transport by cross-linking structural components of the pore 
such that protein conformational changes are blocked. This 
can be tested using Fab fragments, however, so far we have 
been unable to prepare Fab fragments from RL1  that retain 
their high-affinity binding on immunoblots. 
Wheat germ agglutinin (WGA), a lectin that binds to N-ace- 
tyl glucosamine and sialic acids, also blocks protein import 
into nuclei in vitro (22) and in vivo (8, 54). WGA binds to 
sites on the nuclear pore complex as well as to numerous 
other sites within the nucleus and in the cytoplasm (10, 22, 
29, 48). Although it is possible that inhibition by WGA is due 
to binding to the pore complex, indirect inhibition of nuclear 
protein import due to binding to other sites in the nucleus and 
cytoplasm is also conceivable. 
RNA Export Inhibition 
RL1 also inhibits RNA export from the nucleus. This inhibi- 
tion occurs when the antibody is injected either into the nu- 
cleus or cytoplasm. Since the RL1 antigens are known to be 
distributed on both faces of the pore (49), this is not surpris- 
ing. Inhibition is most effective from the nucleoplasmic side 
of the envelope. This could be accounted for by the fact that 
the antibody is more concentrated in the nucleus than in the 
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plasm during the nuclear injections, so compounding the in- 
hibitory effect, or RL1  may interact  with different compo- 
nents on the nucleoplasmic face, resulting in more marked 
inhibition. In rat liver nuclear envelopes one epitope, found 
only on the 180,000-Mr polypeptide, is disposed only on the 
nucleoplasmic face of the pore complex (49).  It is possible 
that all RL1 antigens are asymmetrically distributed between 
the nuclear and cytoplasmic sides of the envelope, therefore, 
one might expect different effects when the antibodies are ap- 
plied to different  faces of the pore. 
Transport of tRNA and 5S RNA was differentially inhib- 
ited by RLI. 5S RNA export was inhibited more than that of 
tRNA. This may reflect packaging of RNA into RNP parti- 
cles. When 5S RNA is injected into oocytes it is transported 
to nucleoli (12), the site of ribosome assembly, where it may 
be packaged into large ribosomal subunits  before export to 
the  cytoplasm.  It  is  thus  possible  that  newly  synthesized 
tRNA is exported more rapidly  than 5S RNP particles and 
the observed inhibition of transport  may, therefore,  be less 
marked for tRNA. 
In summary, we have demonstrated that an antibody against 
the  nuclear  pore  complex  specifically  inhibits  mediated 
transport in both directions across the nuclear envelope. This 
inhibition seems to be an effect on the mediated functions of 
the pore complex but not on the ability to support diffusion 
of small proteins. The antibody thus distinguishes between 
these two properties of the pore complex.  This provides a 
good basis from which to pursue the role of these unusual 
glycoproteins in the function of the pore complex. 
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